 |
인쇄하기
취소
|
Kolmar exclusively to distribute AI vaccine in Korea.
Korea Kolmar (CEO: Yoon Dong-han) announced that they made an exclusive distribution agreement for AI vaccine with Vaxin, an American vaccine manufacturer and bio venture company, on Dec. 12 including a stock investment with them.
2 vaccines in the agreement included a nasal spraying type of flu vaccine and AI vaccine, which are on preparation of phase II clinical studies in the United State...
2 vaccines in the agreement included a nasal spraying type of flu vaccine and AI vaccine, which are on preparation of phase II clinical studies in the United State...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.